Dulac Edward J III
Intellia Therapeutics, Inc. · EVP
Dulac Edward J III is listed in public filings as officer: EVP, Chief Financial Officer. This Dulac Edward J III insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Intellia Therapeutics, Inc. (NTLA). Investors use Dulac Edward J III's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.2M87.5k shares | Grant / ExerciseMar 1, 2026 | $1.2M87.5k shares | $13.78 | -- | |
| --161k shares | Grant / ExerciseMar 1, 2026 | Disclosure amount unavailable61.3k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $918k99.7k shares | SellJan 5, 2026 | $58.8K6.4k shares | $9.21 | -- | |
| $1.5M106.1k shares | SellJul 23, 2025 | $104.6K7.5k shares | $14.02 | -- | |
| $680k67.4k shares | Grant / ExerciseMar 1, 2025 | $680.4K67.4k shares | $10.09 | -- | |
| --113.5k shares | Grant / ExerciseMar 1, 2025 | Disclosure amount unavailable47.2k shares | -- | -- | |
| $2.4M96.2k shares | Grant / ExerciseJul 22, 2024 | $2.4M96.2k shares | $25.33 | -- | |
| --66.3k shares | Grant / ExerciseJul 22, 2024 | Disclosure amount unavailable66.3k shares | -- | -- |